Related Experiment Video

Updated: Jun 2, 2026

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
12:27

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes

Published on: January 3, 2020

Therapies against virulence products of Staphylococcus aureus and Pseudomonas aeruginosa

Jeanine P Wiener-Kronish1, Jean-Francois Pittet

  • 1Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, Massachusetts 02114, USA. jwiener-kronish@partners.org

Seminars in Respiratory and Critical Care Medicine
|April 21, 2011
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa are difficult-to-treat resistant bacteria. Targeting their virulence factors offers a promising strategy for developing new therapies against these critical pathogens.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa are significant hospital-acquired pathogens.
  • Both bacteria exhibit extensive antibiotic resistance and possess virulence factors complicating infections.
  • Emergence of community-acquired MRSA with Panton-Valentine leukocidin (PVL) poses a growing global health concern.

Purpose of the Study:

  • To review potential therapeutic targets within the virulence systems of MRSA and P. aeruginosa.
  • To explore novel strategies for combating infections caused by these antibiotic-resistant bacteria.

Main Methods:

  • Literature review of virulence factors and therapeutic targets in MRSA and P. aeruginosa.
  • Analysis of current research on targeting bacterial virulence for treatment.

Main Results:

  • Identification of key virulence factors in MRSA and P. aeruginosa contributing to pathogenicity.
  • Discussion of the therapeutic potential of targeting these specific virulence mechanisms.

Conclusions:

  • Targeting virulence factors represents a viable alternative to traditional antibiotic development for resistant bacteria.
  • Further research into MRSA and P. aeruginosa virulence systems could lead to effective new treatments for critical infections.

More Related Videos

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...